Dvt - Deep Vein Thrombosis Clinical Trials
2 recruiting trials for Dvt - Deep Vein Thrombosis. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Dvt - Deep Vein Thrombosis clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Al-Nahrain University (1), Chinese PLA General Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is GCS (device, 1 trial), followed by LMWH, This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention..
Track Dvt - Deep Vein Thrombosis trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Predictive Value of Modified Caprini Score and D-Dimer in Managing Lower Limb Venous Thrombosis in Cardiothoracic...
The goal of this observational study is to evaluate the predictive efficacy of the Modified Caprini Risk Assessment Score and D-Dimer in identifying and managing lower extremity...
Clinical Application of Wearable Ultrasound Sensors
This study aims to develop and evaluate a wearable ultrasound imaging sensor for the early diagnosis and real-time monitoring of various diseases, such as cardiovascular...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Dvt - Deep Vein Thrombosis, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Dvt - Deep Vein Thrombosis, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Dvt - Deep Vein Thrombosis, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.